Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity

Activated protein C variants with normal cytoprotective activity but reduced anticoagulant activity

US Patent 7498305 · Granted Mar 3, 2009

Estimated economic value: $8,154,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Monocyclic compounds useful as GPR120 modulators2024
Bicyclic compounds useful as GPR120 modulators2024
Monocyclic compounds useful as GPR120 modulators2023
Bicyclic compounds useful as GPR120 modulators2020
Monocyclic compounds useful as GPR120 modulators2020
Therapy for treatment or prevention of conditions associated with bleeding or hy2019
Therapy for treatment or prevention of conditions associated with bleeding or hy2019
Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and rel2019
Protease activated receptor-1 (PAR1) derived cytoprotective polypeptides and rel2019
Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Rel2017
Protease Activated Receptor-1 (PAR1) Derived Cytoprotective Polypeptides and Rel2017
Activated protein C variants with normal cytoprotective activity but reduced ant2015